A Clinical Study to Evaluate the Remote Monitoring of Myopia Patients With the EyeQue Insight

August 19, 2022 updated by: EyeQue Corp.
The objective of this study is to determine whether the remote monitoring of myopia patients with the EyeQue Insight (visual acuity test) can replace regularly scheduled follow-up visits.

Study Overview

Status

Completed

Conditions

Detailed Description

A prospective exploratory study to determine whether the remote monitoring of myopia patients with the EyeQue Insight (visual acuity test) can replace regularly scheduled follow-up visits.

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Santa Clara, California, United States, 95051
        • Eye Boutique Optometry

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Male or Female
  2. Ages =>7 y.o.
  3. Subjects that are minors (<18 years old) must have a parent or legal guardian.
  4. Binocular vision
  5. Willing and able to give informed consent and follow all study procedures and requirements
  6. Fluent in English
  7. Be treated for myopia with Ortho-K, day contacts, or night contacts

Exclusion Criteria:

  1. Has been diagnosed within 4 weeks, or currently has signs or symptoms, of COVID-19.
  2. Has traveled outside the country within the last 4 weeks
  3. Medications:

    a. Taking medications that may affect ability to follow instructions.

  4. Eye Disease:

    a. Subjects with eye disease deemed by the Investigator to be inappropriate for the study such as an active eye infection, keratoconus, etc.

  5. Subjects that:

    1. Lack physical dexterity to properly operate the EyeQue App on the smartphone
    2. Lack the ability to follow instruction
    3. Lack binocular vision
    4. Lack the ability to maintain both eyes open
    5. Had eye surgery within the last 12 months (including Lasik)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Hand-held Device Supported by Mobile Application
Insight device ETDRS measurement compared to a standard ETDRS chart
The Insight will be compared to a standard ETDRS eyechart

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Departure from scheduled follow-up visits with clinical confirmation
Time Frame: Approximately 21 Weeks
Site will monitor the patient remotely and determine if the subject should depart from their scheduled visits based on at-home testing. If visit departure is warranted the site will examine them in the office and confirm if a departure from normally schedule visit was warranted.
Approximately 21 Weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measure rapidly changing visual acuity
Time Frame: Approximately 21 Weeks
Ability to track and measure visual acuity with the EyeQue Insight in patients with rapidly changing visual acuity during the first month of Ortho-K introduction.
Approximately 21 Weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 3, 2020

Primary Completion (Actual)

September 10, 2021

Study Completion (Actual)

September 10, 2021

Study Registration Dates

First Submitted

December 29, 2020

First Submitted That Met QC Criteria

December 30, 2020

First Posted (Actual)

January 5, 2021

Study Record Updates

Last Update Posted (Actual)

August 22, 2022

Last Update Submitted That Met QC Criteria

August 19, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EYEQUE - 007

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia

Clinical Trials on Visual Acuity with a Hand-held Device Supported by Mobile App.

Subscribe